1.Cas No: 13189-98-5.
2.Molecular formula: C6H13NO3S>
4. Melting point : 200-202°C (dec.)
5. Boiling point: 354.5±42.0 °C(Predicted)
6. Density: 1.301±0.06 g/cm3(Predicted)
7. Storage conditions:-20°C Freezer
Introduce: Fudosteine, chemically known as (-) - (R) - 2-amino-3 - (3-hydroxypropylthio) propionic acid, is a kind of expectorant cysteine derivatives. It has multiple pharmacological effects on chronic respiratory diseases, such as inhibiting the growth of respiratory epithelial cells, inhibiting the proliferation of chemical books, inhibiting the proliferation of respiratory epithelial cells, and inhibiting the proliferation of respiratory epithelial cells, It can normalize the trehalose / sialic acid ratio in sputum, restore the state of cilia transporting airway secretion, and has anti-inflammatory effect; Fudosteine has the advantages of strong efficacy, small side effects, wide indications and great market potential. It is suitable for expectorant treatment of chronic respiratory diseases such as bronchial asthma, chronic bronchitis, bronchiectasis, pulmonary tuberculosis, pneumoconiosis, emphysema, atypical mycobacterium infection, diffuse bronchiolitis, etc.
Application: Fudosteine is suitable for expectoration of bronchial asthma, chronic bronchitis, bronchiectasis, pulmonary tuberculosis, pneumoconiosis, emphysema, atypical mycobacterium infection, diffuse bronchiolitis and other chronic respiratory diseases.
We are Princechem Pharmaceutical manufacturer pass 20 years experience. Types of chemical reactions in are etherification, ammoniation, chlorination, esterification, cyclization, hydrogenation and Grignard reaction, etc..Over the past 10 years, more than 400 catalog products were developed. In recent years, more than 40 kinds of key pharmaceutical intermediates have been developed, involving anti-cancer, cardiovascular, digestive system, mental diseases and other fields. It includes the key intermediates of API such as Quetiapine, Fluvaxamine, Erlotinib, Gefitinib, Sunitinib, Lapatinib, Rabeprazole and Lafutidine. For many years, we have been providing high quality pharmaceutical intermediates for many world-famous pharmaceutical companies.
HI-Tech Enterprise was honored to YPC in 2011. The company adheres to scientific and technological innovation and has more than 10 authorized invention patents.
YPC insists on using the international standard management systems to promote our managements and have established the systems of ISO9001:2000, ISO14001:2004 and OHS18001:1999. Over the past few years, it has passed on-site audits by more than 20 international and domestic pharmaceutical companies.